羟孕酮

qiǎnɡ yùn tónɡ
  • hydroxyprogesterone
羟孕酮羟孕酮
  1. 方法对来自市郊50家妇婴保健医院、产科医院50600例出生3d的新生儿足根刺血,滴于专用采血滤纸上,用酶免疫吸附试验方法测定干血滤纸片上17羟孕酮(17OHP)水平。

    Methods Heel prick blood samples were collected from 50 600 newborns in 50 maternal and child health care hospitals and maternity hospitals 72 hours after their birth and adsorbed onto standard filter paper for determining 17 hydroxyprogesterone ( 17 OHP ) by enzyme linked immunosorbent assay ( ELISA ) .

  2. 肾上腺类固醇与肾上腺脊髓神经病变:硫酸脱氢表雄酮、雄烯二酮和17α-羟孕酮

    Adrenal steroids in adrenomyeloneuropathy : Dehydroepiandrosterone sulfate , androstenedione and 17 α - hydroxyprogesterone

  3. NP方案联合醋酸甲羟孕酮治疗中晚期肺癌

    Combined NP Regimen with Medroxyprogesterone Acetate in Treatment for Advanced Lung Cancer

  4. 方法:对30例EM患者采用保守性手术方法治疗,术后口服醋酸甲羟孕酮作巩固治疗。

    Methods : 30 cases of EM were administered medroxyprogesterone acetate after conservative surgery .

  5. RP-HPLC法测定人血浆中醋酸甲羟孕酮及片剂生物等效性研究

    Determination of medroxyprogesterone acetate in human plasma by RP-HPLC and study of bioequivalence

  6. 方法60例晚期肿瘤病人随机分为两组,A组30例为中药加醋酸甲羟孕酮,B组30例为单纯醋酸甲羟孕酮。

    Methods Sixty patients of advanced cancer were randomly divided into two groups , 30 patients in group A treated with TCM and MPA , 30 patients in group B treated with MPA .

  7. 醋酸甲羟孕酮(MPA)在激素依赖性肿瘤如肾癌、前列腺癌、乳腺癌等治疗上已取得显著疗效。

    Medroxyprogesterone acetate ( MPA ) in hormone-dependent tumors such as renal cancer , prostate cancer , breast cancer treatment has made a significant effect .

  8. 目的:探讨结合雌激素醋酸甲羟孕酮(Pre)替代防治绝经后妇女的血脂紊乱及心血管疾病。

    AIM : To investigate conjugated estrogens medroxyprogesterone acetate ( Pre ) in prevention and treatment of blood lipid disorder and cardiovascular disease for postmenopause women .

  9. 方法分别采用醋酸甲羟孕酮4~20mg/d口服和醋酸亮丙瑞林60~90μg/(kg·月),每4周1次,皮下注射治疗女童性早熟74例。

    Methods Seventy-four with CPP were treated with medroxyprogesterone acetate 4 ~ 20 mg / d orally and leuprorelin acetate 60 ~ 90 μ g / kg subcutaneously injection at monthly intervals .

  10. 目的观察醋酸甲羟孕酮(DMPA)对妇女骨质代谢的影响。

    Objective To observe the effect of depo-medroxyprogesterone acetate ( DMPA ) on bone metabolism in women .

  11. 方法:1)建立复方结合雌激素片剂中安宫黄体酮(又名:醋酸甲羟孕酮Medroxyprogesteroneacetate,MPA)和结合雌激素(ConjugatedEstrogens,CE)的含量测定方法一高效液相色谱法。

    Identification of medroxyprogesterone acetate tablets by infrared spectrophotometry Methods : 1 ) To develop a HPLC method for the determination of medroxyprogesterone acetate ( MPA ) and conjugated estrogens ( CE ) .

  12. 患者血ACTH异常升高,而血皮质醇、性激素水平极低,血清17-羟孕酮降低。结果10例患者均存在第二性征不发育、高血压、低血钾;

    Results Three patients presenting hypertension , hypokalemia and sexual infantilism had abnormally high levels of ACTH , low levels of cortisol and sex steroids , low levels of 17-hydroxyprogesterone .

  13. 扫描方式为选择反应监测(SRM),用于定量分析的二级碎片离子m/z分别为327.4(醋酸甲羟孕酮)和325.4(醋酸甲地孕酮,内标)。

    The scanner mode was selection response monitor ( SRM ) . The second order fragment ion of monitor was at 327.4 ( medroxyprogesterone acetate ) and m / z 325.4 ( megestrol acetate , internal standard ) .

  14. 目的探讨不同剂量醋酸甲羟孕酮(DMPA)用于哺乳期妇女避孕对其避孕效果、副反应发生率及停用原因的影响。

    Objective To discuss the effects of contraception by different dosage of DMPA on the breast feeding women , as well as the side effects and the cause of having to stop the medicine .

  15. 方法将140例围绝经期和绝经后妇女随机分为4组,给药方案分别是:A组(35例):每日戊酸雌二醇(E2V)1mg+醋酸甲羟孕酮(MPA)2mg;

    Methods One hundred and forty peri - and post - menopausal women were randomly divided into 4 groups : group A ( 35 cases ) received estradiol valerate ( E_2V ) 1 mg + medroxyprogesterone acetate ( MPA ) 2 mg per day ;

  16. 术后巩固治疗推荐口服醋酸甲羟孕酮。

    Medroxyprogesterone acetate is recommended in the adjuvant treatment after surgery .

  17. 大气压化学电离质谱法测定饲料中的醋酸甲羟孕酮

    Determination of Medroxyprogesterone in Feed by LC - APCI - MS

  18. 醋酸甲羟孕酮长效避孕对骨代谢影响的临床研究

    Clinical research of long acting contraception of DMPA on bone metabolism

  19. 醋酸甲羟孕酮抑制血管生成的影响所致恶性肿瘤。

    Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by malignant neoplasm .

  20. 保守性手术联合长效醋酸甲羟孕酮治疗中重度子宫内膜异位症的临床观察

    Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis

  21. 首次使用长效醋酸甲羟孕酮患者2年中骨密度的改变

    Bone mineral density changes over two years in firsttime users of depot medroxyprogesterone acetate

  22. 不同剂量醋酸甲羟孕酮用于哺乳期妇女避孕的临床研究。

    A clinical study on contraception of breast-feeding women with different dosage of dmpa .

  23. 以AUC0-48计算的醋酸甲羟孕酮片剂的相对生物利用度为(100.3±6.9)%。

    The relative bioavailability of medroxyprogesterone acetate tablets was ( 100.3 ± 6.9 ) % .

  24. 甲羟孕酮并用达那唑治疗功能失调性子宫出血33例分析

    The Analysis of 33 Cases of Dysfunctional Uterine Bleeding Patients Treated by Medrysone Combined Danazol

  25. 戊酸雌二醇与醋甲羟孕酮联合应用预防绝经近期低骨量妇女骨丢失的作用

    Prevention of bone loss by estradiol valerate combined with medroxyprogesterone acetate among postmenopausal women with osteopenia

  26. 羊水17羟孕酮的酶免疫法测定

    Enzyme Immunoassay of Amniotic Fluid 17-Hydroxyprogesterone

  27. 目的建立醋酸甲羟孕酮片红外光谱鉴别方法。

    OBJECTIVE To establish a rapid and exclusive method for the identification of medroxyprogesterone acetate tablets .

  28. 我想要甲羟孕酮避孕针。

    I want to get depo-provera .

  29. 甲羟孕酮对孕激素受体阳性/阴性癌组织诱导血管形成的抑制作用

    Inhibition of Medroxyprogesterone Acetate on Angiogenesis Induced by Carcinoma Tissue of Progestin Receptor Positive or Negative

  30. 以参比制剂甲羟孕酮片为标准,算得甲羟孕酮胶囊的相对生物利用度为(97.5±8.81)%。

    The relative bioavailability of capsules comparing with tablets was ( 97.5 ± 8.81 ) % .